Douglas W. Bonhaus - Concepedia

Author

Douglas W. Bonhaus

Also Known As

D Bonhaus, D W Bonhaus, D. Bonhaus, D. W. BONHAUS, D. W. Bonhaus, D.W BONHAUS, D.W. Bonhaus, DOUGLAS W BONHAUS, Douglas Bonhaus, Douglas W Bonhaus

101

Publications

4.7K

Citations

H-Index

Concepts

All Affiliations

Institute of Organic Chemistry Acadia Pharmaceuticals (United States)Duke Medical Center University of California San Diego University of Arizona

About

Douglas W. Bonhaus is an author at Institute of Organic Chemistry specializing in medicine, pharmacology, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	37	2.7K
2	Social Sciences	13	14	876
3	Health Sciences	3	3	446
4	Natural Sciences	3	3	177
5	Engineering	1	1	29

Douglas W. Bonhaus

Publications

4.4K

Citations

H-Index

Page 1

	Year	Citations
The 5-HT<sub>3</sub>Subtype of Serotonin Receptor Contributes to Nociceptive Processing via a Novel Subset of Myelinated and Unmyelinated Nociceptors Karla P. Zeitz, Nicolas Guy, Annika B. Malmberg, Journal of Neuroscience Serotonin Receptor ContributesNeuropathic PainMolecular PainNeuroimmunologyReceptor Subtype	2002	369
The pharmacology and distribution of human 5‐hydroxytryptamine<sub>2B</sub> (5‐HT<sub>2b</sub>) receptor gene products: comparison with 5‐HT<sub>2a</sub> and 5‐HT<sub>2c</sub> receptors Douglas W. Bonhaus, Chinh Bach, Andrea DeSouza, British Journal of Pharmacology Splice VariantPharmacotherapyExperimental PharmacologyReceptor Gene ProductsMolecular Pharmacology	1995	301
RS-102221: A Novel High Affinity and Selective, 5-HT 2C Receptor Antagonist Douglas W. Bonhaus, Klaus K. Weinhardt, Marianne Taylor, Neuropharmacology Novel High AffinityMolecular PharmacologyBiochemistryFunctional SelectivityMedicine	1997	255
Dual Activation and Inhibition of Adenylyl Cyclase by Cannabinoid Receptor Agonists: Evidence for Agonist-Specific Trafficking of Intracellular Responses Douglas W. Bonhaus, Leon Chang, Joyce Kwan, Journal of Pharmacology and Experimental Therapeutics	1998	223
Characterization and distribution of putative 5‐ht<sub>7</sub>receptors in guinea‐pig brain Z. P. To, Douglas W. Bonhaus, Richard M. Eglen, British Journal of Pharmacology	1995	221
The kindling model of epilepsy: a critical review. James O McNamara, Douglas W. Bonhaus, Chul-Jin Shin, PubMed Kindling StudiesCritical ReviewBrain MechanismAffective NeuroscienceNeuromodulation Therapies	1985	185
Cloning and Expression of a 5‐Hydroxytryptamine<sub>7</sub> Receptor Positively Coupled to Adenylyl Cyclase Ann‐Ping Tsou, Alan Kosaka, Chinh Bach, Journal of Neurochemistry Adenylyl CyclaseSynaptic TransmissionSynaptic SignalingSocial SciencesMolecular Pharmacology	1994	182
The interaction of RS 25259‐197, a potent and selective antagonist, with 5‐HT<sub>3</sub> receptors, <i>in vitro</i> Erik H.F. Wong, Robin D. Clark, Edward Leung, British Journal of Pharmacology	1995	170
Ligand Efficacy and Potency at Recombinant α2 Adrenergic Receptors Jeffrey R. Jasper, John Lesnick, Leon Chang, Biochemical Pharmacology Molecular PharmacologyMedicinePhysiologyReceptor (Biochemistry)Pharmacotherapy	1998	156
The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson’s disease D. L. Price, Maya A. Koike, Asma Khan, Scientific Reports	2018	154

Page 1